Background: The pathogenesis of severe asthma in childhood remains poorly understood. Objective: We sought to construct the immunologic landscape in the airways of children with severe asthma. Methods: Comprehensive analysis of multiple cell types and mediators was performed by using flow cytometry and a multiplex assay with bronchoalveolar lavage (BAL) specimens (n 5 68) from 52 highly characterized allergic and nonallergic children (0.5-17 years) with severe treatment-refractory asthma. Multiple relationships were tested by using linear mixed-effects modeling. Results: Memory CCR5
1 T H 1 cells were enriched in BAL fluid versus blood, and pathogenic respiratory viruses and bacteria were readily detected. IFN-g 1 IL-17 1 and IFN-g 2 IL-17 1 subsets constituted secondary T H types, and BAL fluid CD8 1 T cells were almost exclusively IFN-g 1 . The T H 17-associated mediators IL-23 and macrophage inflammatory protein 3a/ CCL20 were highly expressed. Despite low T H 2 numbers, T H 2 cytokines were detected, and T H 2 skewing correlated with total IgE levels. Type 2 innate lymphoid cells and basophils were scarce in BAL fluid. Levels of IL-5, IL-33, and IL-28A/IFN-l2 were increased in multisensitized children and correlated with IgE levels to dust mite, ryegrass, and fungi but not cat, ragweed, or food sources. Additionally, levels of IL-5, but no other cytokine, increased with age and correlated with eosinophil numbers in BAL fluid and blood. Both plasmacytoid and Asthma is an inflammatory disease of the airways characterized by intermittent airflow limitation beginning in childhood. Unfortunately, a subset of children experience severe symptoms and recurrent exacerbations despite treatment. 1 Such refractory asthma exacts a major health and economic toll on society and presents a clinical dilemma. Understanding the characteristic Tcell milieu in the lower airways of children with treatmentrefractory asthma could fill gaps in the understanding of severe asthma and provide new opportunities for intervention. CD4 1 T cells are pivotal to the development and maintenance of inflammatory processes in the asthmatic lung. For many years, T H 2 cells remained at the forefront because of their link to IgE production in patients with allergic asthma and the pathogenic effects of IL-4 and IL-13 on airway inflammation. 2, 3 However, asthma is now known to comprise heterogeneous phenotypes that reflect different underlying immune mechanisms. 4 Severe asthma endotypes include IL-5-mediated eosinophilic disorders that can occur independently of IL-4, 5 as well as lung neutrophilia promoted by T H 17 cells. 6, 7 However, the distinction between these disease entities is not clear-cut. Indeed, both eosinophils and neutrophils populate the airways of patients with severe asthma, pointing to complex immunopathology. 8 In this context, the presence of T cells in the lungs that express multiple cytokines and do not adhere to conventional types is perhaps not surprising. For example, CD4 1 T cells coexpressing IL-4 and IL-17A (T H 2/ T H 17) have been linked to reduced lung function in adults with severe treatment-refractory asthma. 9 By contrast, secretion of the T H 1-associated cytokine IFN-g, as well as IL-13, was found to be a prominent feature of cultured cells isolated from the airways of adults with severe but not mild disease. 10 Together, these findings indicate the persistence of complex T-cell types despite treatment.
Analyzing the T-cell landscape in children with severe asthma poses challenges because of the scarcity and inaccessibility of T cells in inflamed airways. Hence the nature of T cells in the lower airways remains enigmatic. Moreover, T-cell phenotypes within the broader context of the cytokine milieu have not been evaluated. Here we report a comprehensive assessment of T-cell signatures in bronchoalveolar lavage (BAL) fluid specimens obtained from a well-characterized cohort of highly symptomatic asthmatic children. Through paralleled analysis of multiple cell types and secreted cytokines that are instrumental to adaptive immunity at the epithelial interface, we confirm a dominant T H 1 signature in a mixed cytokine milieu and identify novel relationships linked to allergic status. Our findings indicate the establishment of T H 1 responses in the airways in early life and support the view that regulation of this response might modify the development of severe asthma.
METHODS

Human subjects and biological specimens
Fifty-two children with severe treatment-refractory asthma (ages, 6 months to 17 years) who underwent clinically indicated bronchoscopy participated in the study. Strict definitions of asthma, asthma severity assignment, and symptom control by age at enrollment were followed (see Table E1 in this article's Online Repository at www.jacionline.org). 1, 11, 12 Demographic and clinical information was obtained for each participant by means of questionnaire and review of the medical record. Subjects were classified as allergic based on a specific IgE level of greater than 0.1 kU A /L to at least 1 of 9 allergens or an increased total IgE level (see the Methods section in this article's Online Repository at www.jacionline.org). Indications for bronchoscopy, procedure details, and subject features are detailed in the Methods section in this article's Online Repository. BAL fluid specimens were obtained, as previously described. 13 In some cases, as clinically indicated, 2 bronchial segments underwent lavage, and the BAL fluid return was processed separately. Venous blood specimens were obtained for flow cytometry in a subset of subjects. Informed consent and subject assent, when indicated, were obtained. The study was approved by the University of Virginia Human Investigations Committee. 
Abbreviations used
Detection of respiratory microbes
Detection of viruses and bacteria was assessed as described in the Methods section in this article's Online Repository.
Antibodies for flow cytometry and other reagents
Details of antibodies for flow cytometry and other reagents are provided in Table E2 in this article's Online Repository at www.jacionline.org.
Flow cytometry
Cells were analyzed from BAL fluid specimens and in available blood. Specimens were processed immediately to maximize cell viability and maintain phenotypic markers. BAL fluid cells were isolated by means of centrifugation, and supernatant fluid was frozen and stored at 2808C for later analysis. In cases in which BAL fluid samples were available from 2 lung regions, cells from the right middle lobe (n 5 17), lingula of the left lung (n 5 2), or left lower lobe (n 5 1) were analyzed. PBMCs were isolated by using established methods.
14 Cell-surface and intracellular markers were assessed by using multicolor flow cytometry with established methods (see the Methods section in this article's Online Repository). [14] [15] [16] Data were acquired with FACSDiva software (version 8.0; BD Biosciences, San Jose, Calif) and analyzed with FlowJo 9.6 software (TreeStar, Ashland, Ore). Analysis of complex cytokine-positive cell populations was performed with SPICE, version 5.3 (downloaded from http://exon.niaid.nih.gov). 17 Cytokine assay BAL fluid supernatants were assayed for a panel of cytokines by using the cytometric bead assay (Millipore, Billerica, Mass) with a Luminex MAGPIX System (Luminex, Austin, Tex; see the Methods section in this article's Online Repository).
Statistical analysis
Cytokine values in BAL fluid supernatants were log transformed, and absolute concentrations were determined with the R package nCal (https:// CRAN.R-project.org/package5nCal) 18 by using a Bayesian random-effects model to fit the fluorescence intensities. Hierarchical clustering and mixedeffects modeling of cytokines were performed as described in the Methods section in this article's Online Repository. Additional details of statistical tests are also included in the Methods section in this article's Online Repository.
RESULTS
Features of study participants
BAL fluid specimens were available for analysis from 52 children with severe asthma, including 38 allergic and 14 nonallergic subjects (Table I and see Table E1 ). All subjects were receiving daily inhaled corticosteroid treatment at the time of bronchoscopy, and 18 (34%) subjects completed a course of oral corticosteroids within 3 months before bronchoscopy. Levels of serum total IgE were higher among asthmatic patients older than 6 years versus those who were younger (Fig 1, A) . Among younger asthmatic patients, IgE antibodies to cow's milk (58%), cat (35%), and peanut (31%) were common, whereas IgE antibodies to indoor and outdoor inhalant allergens, including fungi, increased with age (P < .05 for dust mite, ryegrass, Aspergilus fumigatus, and Alternaria alternata; Fig  1, B) . Allergic asthmatic patients had higher total IgE levels (geometric mean (GM), 255 vs 12 IU/mL; P < .001) and an increased incidence of blood eosinophilia (70% vs 21%, P < .01; Table I ). The incidence of eosinophils in BAL fluid also trended higher among allergic versus nonallergic asthmatic patients (31% vs 0%, P 5 .09). Most asthmatic patients (92%) had evidence of current or past exposure to respiratory pathogens, as judged by any past pneumonia (73%) and positive PCR results for enterovirus/human rhinovirus (38%) and/or positive bacterial cultures (29%) in BAL fluid (Table I) . Detection of bacteria was more common in nonallergic asthmatic patients (P < .05, Table I ). Among those with positive culture results, IgE levels trended lower (GM, 46.22 vs 125.8 IU/mL; P 5 .10), and the majority were 6 years or younger (10/14 [71%], see Fig E1, A, in this article's Online Repository at www.jacionline.org). Overall, 51% of children had any infectious microbes detected. Cultured bacteria included Streptococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenzae, and Staphylococcus aureus. Three of 5 subjects colonized with S pneumoniae were also colonized with H influenzae and/or M catarrhalis. Serum IgA and IgG levels were within normal range and did not differ according to bacterial culture status (see Fig E1, A) . BAL fluid neutrophils (> _1% total cells) were a prominent feature among asthmatic patients, regardless of bacterial culture or allergic status (Table I and see Fig E1, B) .
CCR5
1 memory T cells are enriched in BAL fluid of children with severe asthma BAL fluid specimens from 37 children who were representative of the study group contained a minimum of 1000 live single T-cell events that were sufficient for analysis by using flow cytometry (see Fig E2 in 
CD4
1 T cells compared with peripheral blood (GM, 74% vs 24%; P < .0001) and contained a higher proportion of memory T cells expressing CCR5 (GM, 23% vs 3%; P < .0001; Fig 2, A and B, and see Fig E3, A, in this article's Online Repository at www.jacionline.org). This T H 1-associated chemoattractant receptor has been implicated in directing T-cell immunity to respiratory viruses. [19] [20] [21] [22] [23] Serum total IgE levels were positively correlated with numbers of CCR5
1
CD4
1 T cells in BAL fluid (r 5 0.47, P 5 .05; Fig 2, C) and, to a lesser extent, in the blood (r 5 0.45, P 5.06), although statistical significance was not maintained after adjusting for subject's age and dose of inhaled corticosteroids (BAL fluid: r 5 0.46, P 5 .07). Analysis of total live T lymphocytes in BAL fluid showed a lower ratio of CD4
1
/CD8
1 T cells in the nonallergic group that was not significant (GM, 0.60 vs 1.01; P 5 .25; see Fig E3, B) . Expression of CD45RO and CCR5 on CD8
1 T cells in BAL fluid was comparable with that on CD4
1
T cells (Fig 2, A , and see Fig E3, C) . Together, these findings suggest recruitment of T H 1-like cells in patients with severe asthma, irrespective of allergic status. 
IFN-g
CD4
1 T cells in BAL fluid and their marked augmentation compared with numbers in blood (GM, 48% vs 6%; P <.01; Fig 2, D) . Similarly, IL-17A 1 cells were enriched in BAL fluid (GM, 7% vs 0.1%; P < .01), and although generally less frequent than IFN-g 1 T cells, they constituted up to approximately 40% of CD4 1 T cells in some asthmatic patients. By contrast, the percentage of T H 2 cells (IL-4 1 or IL-5
1
) comprised less than 10% of CD4 1 T cells in both BAL fluid and blood.
Cytokine expression in memory CD4 1 T cells in BAL fluid reflected the IFN-g-dominated profile of total CD4 1 T cells (Fig  2, E) . Analysis of memory CD8
1 T cells in BAL fluid revealed higher IFN-g levels and lower expression of IL-4, IL-5, and IL-17A compared with CD4 1 T cells, which is consistent with a dominant type 1 cytotoxic T (T C 1) cell phenotype (Fig 2, E , and see Fig E4 in this article's Online Repository at www. jacionline.org).
Expansion of the cytokine panel to include IL-13, which is pivotal to airway hyperresponsiveness in models of allergic asthma, 24 revealed that IL-13 1 CD4 1 T cells were infrequent (Fig 3, A) . By using SPICE software 17 to visualize T-cell heterogeneity according to all 5 cytokines tested, the dominant memory CD4
1 T-cell subsets were either IFN-g 1 only, IL-17A 1 only, or else IFN-g 
IL-17A
1 only. This was consistent for subjects with variable age, allergic status, and bacterial culture status (Fig 3, B and C) . Infrequent IL-5
1 and IL-13 1 T cells coexpressed IL-4, although rare cells expressing IL-5 or IL-13 either alone or in combination with IL-17A or IFN-g were also detectable (Fig 3,  A and B) . Collectively, these findings demonstrated that T H 1 and T C 1 cells were the dominant cell types in airway lumen of children with severe asthma. Both T H 1-and T H 2-associated cytokines are increased in BAL fluid of asthmatic patients sensitized to inhalant allergens Sixty-eight BAL fluid specimens from 48 asthmatic patients (35 allergic and 13 nonallergic) were available for analysis of a broad array of secreted cytokines by using a bead-based multiplex assay (see Fig E2) . These included specimens obtained from 2 different lung regions in 20 asthmatic patients. Heat map analysis revealed variations in cytokine profiles among different subjects (Fig 4, A) . However, similar profiles were observed for different lung regions sampled within the same subject (see Fig E6 in this article's Online Repository at www.jacionline.org). Proinflammatory cytokines expressed by epithelial cells (IL-1b, IL-6, IL-33, and the potent chemoattractant macrophage inflammatory protein [MIP] 3a/CCL20) were expressed at high levels (Fig 4,  B) . The most abundant T cell-associated cytokines expressed were IL-23, IL-27, IL-28A/IFN-l2, and canonical T H 2 cytokines (IL-4, IL-5, and IL-13), as well as IL-31; however, IFN-g levels were generally low (Fig 4, B) . Cluster analyses did not reveal discrete profiles linked to higher levels of T H 1-or T H 2-associated cytokines.
Next, we applied a sensitive and precise linear mixed-effects modeling approach based on median fluorescence intensity (MFI) values for cytokines to test relationships to patient characteristics (see the Statistical analysis section in this article's Online Repository for details). 25 By using this strategy, no significant differences in cytokine levels were identified between allergic and nonallergic groups as a whole. By contrast, differences were observed based on the presence of specific IgE. Notably, levels of IL-33, IL-28A/IFN-l2, and IL-5 were greater among asthmatic patients who had specific IgE to inhalant allergens, including dust mite, ryegrass, Aspergillus fumigatus, and Alternaria alternata, compared with those who did not, with consistently strong relationships identified for IL-33 and IL-5 (P < _.0001; Fig 5 and Table II) . Moreover, levels of specific IgE to Alternaria alternata were associated with increased levels of a broader array of T H 1/T H 2-promoting cytokines compared with other sensitivities (Table II) . No significant relationships were identified for cat, ragweed, or any of the food allergens tested (egg, cow's milk, and peanut). Moreover, sensitization to multiple allergens (IgE to >3 allergens) was associated with higher levels of IL-5, IL-33, and IL-28A/IFNl2 compared with those in nonallergic asthmatic patients (Table II) . Analysis of other relationships identified greater expression of the proinflammatory cytokines TNF-a and IL1b among asthmatic patients with positive versus negative bacterial cultures (P 5 .002 and P 5 .042, respectively) and higher levels of IL-5 among older children when testing age as a continuous variable (P < .001). This latter relationship was maintained within the allergic but not the nonallergic group (P 5 .02 vs P 5 .65, respectively). IL-5 levels were also correlated with blood eosinophil counts (P 5 .02) and were greater among those asthmatic patients who had detectable eosinophils in BAL fluid versus those who did not (P 5 .0014, see 
A B
Allergic (n=38) Non-allergic (n=14) Serum IgE levels increase with age in children with severe asthma. A, Total serum IgE levels in children according to age. **P < .01. B, Levels of specific IgE antibodies in children according to age. Bars denote GMs of positive values, and dashed lines denote the limit of sensitivity of the assay. *P < .05 compared with children 6 years and younger. D. pter, Dermatophagoides pteronyssinus (dust mite). The prevalence of allergy according to age was as follows: 6 months to 6 years, allergic (n 5 16) and nonallergic (n 5 10); >6 years, allergic (n 5 22) and nonallergic (n 5 4). 
Type 2 innate lymphoid cells are present in BAL fluid
Given our ability to detect IL-4, IL-5, and IL-13 in BAL fluid despite low numbers of T H 2 cells, we sought to identify type 2 innate lymphoid cells (ILC2s) as a potential alternative source. These lineage (Lin) 2 cells, which reside at the epithelial interface, secrete T H 2 cytokines in response to IL-33. Of 9 BAL fluid specimens analyzed, 7 had detectable innate lymphoid cells, which included IL-4 1 or IL-13 1 ILC2s at low numbers (<2.5% of total live single-cell events). Expression of the ILC2 marker chemoattractant receptor-homologous molecule expressed on T H 2 lymphocytes (CRTH2) was a feature of these cells (see Fig  E8 in this article' s Online Repository at www.jacionline.org).
Myeloid and plasmacytoid dendritic cells are present in BAL fluid
We sought to identify whether dendritic cell types necessary to promote distinct T H subsets were present in the airways. Although myeloid dendritic cells (mDCs) initiate and maintain T H 2 responses in asthmatic patients, 26, 27 plasmacytoid dendritic cells (pDCs) induce T H 1 responses through production of type I and Samples with detectable signals less than the standard curve are colored blue to white, whereas samples within standard curve ranges (>0.02 pg/mL) are scaled red. Green bars (top of heat map) denote samples from allergic subjects. B, Violin plots of cytokine levels for BAL fluid specimens and relationship to the standard curve (black open dots). Each dot corresponds to the ''average'' concentration for a given subject derived from all observed MFI values run in at least duplicates and interpolated from the standard curve. Red, green, and blue dots correspond to BAL fluid specimens from multisensitized (IgE to >3 allergens; 18 subjects), allergic (IgE to 1-3 allergens; 16 subjects), and nonallergic (14 subjects) asthmatic patients, respectively. Horizontal line denotes the lowest value of all standard curves (0.02 pg/mL).
J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 6 type III interferons. 28 Analysis of BAL fluid identified mDCs and pDCs based on expression of characteristic markers (Fig 6, A , and see Fig E9 in this article's Online Repository at www.jacionline. org). 29 Although numbers of mDCs and pDCs were comparable between BAL fluid and blood specimens, basophils, a major innate source of T H 2 cytokines, were scarce in BAL fluid compared with blood (Fig 6, A and B) . Both pDCs and mDCs in BAL fluid expressed FcεRI (Fig 6, C and D) . Those FcεRI with severe asthma. T-cell expression of the T H 1-associated chemokine receptor CCR5, which has been implicated in directing T-cell responses to respiratory viruses, was notable in this regard. [21] [22] [23] The assessment of infectious microbes in the lower airways was a differentiating feature of our study. Bronchoscopy provides a reliable method for sampling microbes in the lower respiratory tract, and evidence of current or past exposure to respiratory pathogens was common in our study, which is consistent with the severe asthma phenotype. 30, 31 This feature might reflect a highly selected patient sample based on treatment failure and poor symptom control. No asthmatic patients had signs or symptoms of an active infection at the time of bronchoscopy; thus detection of microbes might indicate a carrier state. Nonetheless, given the epidemiologic link between childhood asthma and exposure to respiratory viruses in particular, 32 establishment of an IFNg-dominated T-cell profile in childhood implies a pathogenic role in the development of severe disease. Moreover, our findings confirm that a T H 1 signature is a feature of severe asthma, even in the face of T H 2-promoting elements and allergic sensitization. This notion aligns with proof-of-concept work recently reported in mice in which coadministration of bacterial components with allergen induced severe asthma in a T H 1-mediated fashion. 
IFN-g 1 T cells constituted the most abundant CD4
1 subsets detected, regardless of allergic status. The role of such cells in patients with severe asthma remains enigmatic; however, there is intriguing new evidence to support an association between ''T H 17-high'' asthma and an altered neutrophil phenotype among adults with severe asthma. 33 IL-17 1 IFN-g 1 T cells have been linked previously to diseases with autoimmune underpinnings. 34, 35 These cells can be generated in vitro under T H 17-promoting conditions, are more plastic than their single-positive counterparts, and can promote production of inflammatory mediators by epithelial cells. 36 The T H 17-promoting cytokine IL-23 has been linked to asthma severity in adults. 37 Its high levels in BAL fluid in the present study suggest that the inflammatory milieu might favor induction of IL-17 1 
IFN-g
1 T cells in situ. Other notable T H 1/T H 17-associated cytokines detected included IL-27 and IL-28/IFNl2. IL-27 is associated with asthma risk and disease severity at both the genetic and protein levels 38, 39 and is integral to interferon-mediated networks in virus-induced exacerbations. 40 Similarly, the type III interferon IL-28A/IFN-l2, levels of which were increased among subjects sensitized to dust mite and fungi in our study, has antiviral properties and is a potent inducer of IFN-g in human T cells. 41, 42 A major strength of our study was use of linear mixed-effects modeling to analyze multiple relationships between cytokine profiles in BAL fluid, allergic status, microbial colonization, and age. By applying the algorithm to fluorescence intensity data, as opposed to protein concentration values, our approach provided an accurate and sensitive analytic method while correcting for biological and technical factors that can affect variations in multiplex assay systems. 25, 43, 44 Older children in our cohort displayed a high prevalence of sensitization to dust mite, ryegrass, and Aspergillus and Alternaria species. Increased levels of IL-33 and IL-5 (as well as IL-28A) in BAL fluid from asthmatic patients sensitized to inhalant but not food allergens was a striking finding, suggesting a role for key allergens in driving their secretion, although cat and ragweed were notable exceptions.
Exposure to multiple fungal allergens, including Alternaria alternata, is emerging as an important factor in asthma hospitalization in children and adolescents with asthma. 45 Notably, severe childhood asthma with fungal sensitization has been linked to IL-33 expression in the airways. 46, 47 This cytokine, which is secreted by epithelial and endothelial cells in response to tissue damage, is not only a potent T H 2-promoting mediator but also contributes to the differentiation and function of T H 1 cells. 48, 49 Whether IL-33 drives T H 1 responses among asthmatic patients sensitized to fungi warrants further study.
On the other hand, the T H 2 cytokine IL-5 is chemotactic for eosinophils, a feature of the exacerbation-prone asthma phenotype in patients with severe asthma. 50 The correlation between BAL fluid IL-5 levels and eosinophil counts in the present study implicates IL-5 in disease pathogenesis, whereas the increase in IL-5 levels with age is consistent with the evolution of T H 2 responses over time. From a broader perspective, our findings highlight the need to re-examine the interplay between immune components that have traditionally been characterized according to the T H 1/ T H 2 dogma.
Despite the robust T H 1 signature in BAL fluid, levels of secreted IFN-g were low but within the range previously reported in children and adults with severe asthma. [51] [52] [53] Interestingly, those studies found similar or lower levels of IFN-g compared with those in healthy control subjects or asthmatic patients with milder disease. 51, 52 Detection of IFN-g by using the multiplex assay is context dependent 54 and might be undermined in BAL fluid by several factors, including degradation by the metalloproteinase ADAM17, which is highly expressed in the inflamed airways 55, 56 ; rapid uptake by airway macrophages 57 ; and limited dispersion compared with other T H cytokines. 58 T-cell exhaustion might also be a factor because of chronic antigenic activation; however, the ability for IFN-g 1 BAL fluid T cells from adults with severe asthma to secrete high levels of IFN-g after in vitro stimulation argues against this notion.
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In relation to T H 2 cytokines, our ability to detect secreted IL-4 was a notable difference from previous work. ILC2s, which were detected in low numbers and have recently been implicated in patients with severe asthma, 5, 47, 59 are unlikely to be a major source of IL-4 in the face of infrequent T H 2 cells and scarce basophils. Instead, more abundant cell types, such as alternatively activated macrophages, might provide a source. 60 Nonetheless, our ability to detect innate lymphoid cells suggests that their further evaluation is warranted in patients with severe asthma. A key question remains regarding the machinery required for T H 1/T C 1 and T H 17 cell enrichment in the lungs. We confirmed the presence of mDCs and pDCs in BAL fluid, both of which can promote differentiation of various T-cell types. The epithelial cellderived chemoattractant MIP-3a, which was present at high levels in BAL fluid, might be pivotal to the recruitment of airway dendritic cells and T H 17 cells through CCR6. 61, 62 Although pDCs are principal instigators of IFN-g responses, the contributions of mDCs and the IgE/interferon axis in particular merit further study. 63 Our study was limited by several constraints. For example, endobronchial biopsy specimens, which could yield insight into T H 1 abundance in inflamed tissues, were not available. 64 Similarly, although induced sputum provides a useful noninvasive proxy for studying inflammatory processes in the lungs, its procurement is not feasible in children of preschool age. Additionally, our study lacked healthy control subjects because of barriers that preclude obtaining BAL fluid specimens for research purposes in children. Asthmatic children not receiving corticosteroids were also not included; however, these subjects would, by definition, have milder disease and thus constitute a distinct endotype. Although an effect of corticosteroids on molecular signatures cannot be excluded in our study, there are scant data to support their T H 1-skewing effects. [65] [66] [67] [68] Indeed, our findings argue against global suppression of T H 2 pathways by corticosteroids based on detection of a variety of canonical T H 2 cytokines in both BAL fluid and T cells. On the other hand, T H 1 cells can actually mediate corticosteroid resistance in mouse models of asthma, 69 thereby supporting their pathogenicity in persistent airway inflammation. From a clinical standpoint, the presence of proinflammatory profiles in BAL fluid of children with severe asthma that is resistant to corticosteroids questions the continued use of this therapy in this context.
In summary, we have confirmed a dominant T H 1 signature in BAL fluid of a subset of children with severe asthma that exists from an early age. Nevertheless, the immune phenotypes observed encompassed a spectrum that deviates from established paradigms. Our findings support the consideration of a multipronged treatment strategy that might involve modifying effects of exposures to inhalant allergens and respiratory microbes by means of dual blockade of T H 1 and T H 2 pathways in early childhood, depending on allergic status. Controlled studies of much larger numbers of children will be necessary to fully elucidate these aspects.
We acknowledge the efforts of our study coordinator, Denise ThompsonBatt, RRT, for her assistance recruiting and consenting families of children undergoing clinical bronchoscopy and procurement of fresh leftover BAL fluid specimens for this study. We thank Joanne Lannigan, MS, and Michael Solga, MS, for technical expertise related to flow cytometry.
Key messages
d T H 1 cells dominate the lower airways of children with severe asthma, regardless of allergic status.
d The association between increased levels of IL-5, IL-33, and IL-28A/IFN-l2 in the airways and specific IgE to inhalant allergens, but not foods, implicates key allergens in promoting atypical cytokine profiles.
d T H 1 cells might provide a therapeutic target for severe asthma in children.
METHODS
Human subjects and bronchoscopy
BAL fluid samples were obtained from 52 children. Indications for bronchoscopy were poorly controlled asthma despite treatment with highdose corticosteroids (Table E1) , recurrent health care access, and recurrent or persistent abnormality on chest film. Participants received specialty care at a regional academic center, and treatment was adjusted by a senior clinician. Adherence to treatment was confirmed by means of analysis of prescription refill pharmacy records, and the inhaled medication technique was evaluated regularly in the clinic. Oral corticosteroid use was obtained from medical record electronic monitoring. Participants were treated with asthma control medications according to the EPR-3 guidelines, with treatment adjusted in follow-up visits to the clinic according to the level of symptom control and lung function. Bronchoscopies were done after achievement of conscious sedation or general anesthesia through a laryngeal mask airway that was transorally inserted in order to avoid contamination through the nasopharynx.
Serum antibody assays
Serum total and specific IgE (dust mite [Dermatophagoides pteronyssinus], cat, egg, cow's milk, peanut, ryegrass, ragweed, Alternaria alternata, and Aspergillus fumigatus) levels were measured by using the ImmunoCAP assay (Phadia US, Portage, Mich) with the ImmunoCAP 250 system. Allergic status was assigned based on the presence of specific IgE by using a low assay threshold (>0.1 kU A /L, n 5 37) or increased total IgE levels according to age (>50 IU/mL for children < _5 years of age, n 5 1). Serum IgG and IgA antibody levels were measured by the University of Virginia Medical Laboratories using Rate Nephelometry (IMMAGE 800 Immunochemistry System; Beckman Coulter, Fullerton, Calif).
Detection of respiratory microbes
Bacteria were detected by means of culture, and respiratory viruses were assessed by using multiplex PCR analysis for the following: influenza A, subtype seasonal H1 or seasonal H3; influenza B; parainfluenza 1, 2, and 3; metapneumovirus; rhinovirus/enterovirus; adenovirus; and respiratory syncytial virus subtypes A and B. Tests were performed through the University of Virginia Medical Laboratories.
Antibodies for flow cytometry and other reagents
Mouse IgG used to block Fc receptors before cell staining was obtained from Lampire Biological Laboratories (Pipersville, Pa). Antibodies used to identify cell populations, including lineage cocktails, are listed in Table E2 . Fixable Aqua Live/Dead Staining Kit was obtained from Invitrogen (Eugene, Ore).
Flow cytometric analysis
Cells were restimulated with phorbol 12-myristate 13-acetate (50 ng/mL; Thermo Fisher Scientific, Waltham, Mass) and 2 mg/mL ionomycin (Invitrogen, Carlsbad, Calif) in the presence of Brefeldin A (BD Biosciences) for 4 hours to detect intracellular cytokines in innate lymphoid cells and T cells. Fig  E8) . The T H 2 lineage-defining transcription factor GATA-3 was not used to identify ILC2s based on its downregulation in a T H 1-associated inflammatory milieu.
E6
Cytometric bead assay for secreted cytokines 
Statistical analysis
Differences in cell numbers or percentages were analyzed within groups by using the nonparametric Wilcoxon signed-rank test for paired data and between groups by using the 2-sample Wilcoxon rank sum test. Because of the limited sample size, allergy was evaluated as a continuous variable, as judged by serum total IgE levels. Associations between cell percentages/ratios, total IgE levels, age, and ICS dose were examined by using univariate and multivariate Spearman correlations. In the multivariate setting partial correlations were determined after adjustment for age, ICS dose, and total IgE levels, where applicable. Between-group differences in the prevalence of IgE and antibody levels were analyzed by using the x 2 and Mann-Whitney U tests, respectively. Heat maps for secreted cytokines were generated as follows: samples were assayed in at least duplicates, and computed concentrations were averaged before plotting. Unsupervised hierarchical clustering was performed for samples by using Euclidean distance and average linkage and for cytokines by using correlation distance and average linkage. For linear mixed-effects modeling, MFI values were used to assess differential expression of cytokines because of the increased sensitivity compared with using derived concentration values. E7 ,E8 Background-corrected MFI values were obtained from the Luminex csv files and imported into the R statistical programming environment (version 3.3).
E9 MFI values were log 10 transformed, and MFI values from the standards and quality control beads for each assay run were used to remove batch effects between different assays. Linear models for each cytokine were generated by using batch-corrected MFI values, and subject source was treated as a random effect to account for variation between subjects. The R package Limma was used to remove batch effects and implement the linear models. E10 Moderated t tests were used to determine the significance of differential expression between groups. Because of the lack of previous data, no power calculation was performed.
A B
Allergic, 6 mo. -6 yrs.
Non-allergic, 6 mo. -6 yrs.
Non-allergic, >6 yrs.
Allergic, >6 yrs. (Fig E5, A) and total IgE and age (Fig E5, B) are shown. A, Allergic; NA, nonallergic. 
